WHO ICTRP trial

Comparing morhine and fentanyl on anti platelet effect of ticagrelor

CTRI/2018/04/013423 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/04/013423
Public title Comparing morhine and fentanyl on anti platelet effect of ticagrelor
Scientific title Comparison of effect of Morphine and fEntanyl on the platelet inhibition of Ticagrelor in patients with acute coronary syndrome - COMET
Primary sponsor SRI RAMACHANDRA MEDICAL COLLEGE AND RESEARCH INSTITUTION
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries India
Conditions Health Condition 1: null- ACUTE CORONARY SYNDROME Health Condition 2: I21- Acute myocardial infarction Health Condition 3: I25- Chronic ischemic heart disease Health Condition 4: I200- Unstable angina
Interventions Intervention1: Morphine: 2 to 8 mg of morphine could be given once every 5 min till side effects happen or symptom subside or maximum of 4 times; Dosage will be reduced to half if age is more than 75 or weight is less than 50 Kg Control…
Registration date Apr 23, 2018
Target size 126
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations